• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Skip to navigation
Close Ad

The Spoon

Daily news and analysis about the food tech revolution

  • Home
  • Podcasts
  • Events
  • Newsletter
  • Connect
    • Custom Events
    • Slack
    • RSS
    • Send us a Tip
  • Advertise
  • Consulting
  • About
The Spoon
  • Home
  • Podcasts
  • Newsletter
  • Events
  • Advertise
  • About

Cell-Based Breastmilk Startup TurtleTree Eyes Lactoferrin as First Commercial Product

by Michael Wolf
June 5, 2021June 5, 2021Filed under:
  • Cellular Agriculture
  • News
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to email this to a friend (Opens in new window)

TurtleTree, a startup developing human breastmilk using cellular agriculture technology, has announced that its first commercially available product will be lactoferrin, a protein found in both animal and cow milk.

Lactoferrin has long been viewed as a critical protein to both fight infection and to aid in brain development of young children, as well as a supplement to help women fight iron deficiencies, has more recently gained traction for its ability to help fight against COVID-19 infection.

While today’s supplement industry uses cow-derived lactoferrin, human breastmilk has 5-7 times the concentration. TurtleTree saw an opportunity.

“We have been able to identify early commercial ingredient targets due to our frequent conversations with prominent performance nutrition and infant formula companies,” said Max Rye, Chief Strategist of TurtleTree. “We’ve since seen tremendous interest from global partners in our portfolio of human and bovine milk products. It is going to be an exciting year for us.”

TurtleTree focus on lactoferrin as it’s first product for scaled commercial production doesn’t mean it’s giving up on creating fully realized cell-based breastmilk. The company is still working on its technology that grows mammary gland cells in a lab which actually lactate milk, but recognizes it could take a few years before cell-based milk can scale and has full regulatory approval.

TurtleTree isn’t the only cell-based breastmilk startup to make the news lately. Earlier this week BioMILQ announced that it has successfully made human breast milk outside the breast. Another, Israel-based BioMilk, is looking to create both human and cow milk analogs and recently became publicly listed on Tel Aviv stock exchange despite being few years out still from commercially scaled production.


Related

Get the Spoon in your inbox

Just enter your email and we’ll take care of the rest:

Find us on some of these other platforms:

  • Apple Podcasts
  • Spotify
Tagged:
  • breast milk
  • TurtleTree
  • TurtleTree Labs

Post navigation

Previous Post Food Tech News: Promising Mealworm Research, Miller Lite Shoezie, and Rewards for Eating Organic Yogurt
Next Post McDonald’s Drive-Thru Plans Need to Factor In Franchisees

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Get The Spoon in Your Inbox

The Spoon Podcast Network!

Feed your mind! Subscribe to one of our podcasts!

How ReShape is Using AI to Accelerate Biotech Research
How Eva Goulbourne Turned Her ‘Party Trick’ Into a Career Building Sustainable Food Systems
Combustion Acquires Recipe App Crouton
Next-Gen Fridge Startup Tomorrow Shuts Down
From Starday to Shiru to Givaudan, AI Is Now Tablestakes Across the Food Value Chain

Footer

  • About
  • Sponsor the Spoon
  • The Spoon Events
  • Spoon Plus

© 2016–2025 The Spoon. All rights reserved.

  • Facebook
  • Instagram
  • LinkedIn
  • RSS
  • Twitter
  • YouTube
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.